According to CBDMT, the Market and business intelligence company, about ten microalgae are used for commercial applications. They are used as a whole without transformation or are used to produce extracts of interest. The total production volume of microalgae for all application is in the tens of thousands of tons. The Algae mostly produced are: Chlorella, Cryptecodinium, Dunaliella, Haematococcus, Spirulina and Ulkenia.
According to CBDMT, the Market and business intelligence company, two kinds of biomanufacturing CMOs exist in Europe: 73% "Multipurpose" CMOs and 27% "AB-only" CMOs for custom monoclonal and polyclonal antibody manufacturing.166 contract biomanufacturing Organizations were identified in the European biomanufacturing market accounting for 229 production sites located in Europe. 49% of Biomanufacturing CMOs are located in Western Europe. More than half of all AB-only biomanufacturers (52%) are located in UK and France.
According to CBDM.T®, the market and business intelligence company, the Dry Eye market is huge and growing valued at 1.7 billion USD in 2009 with an annual growth of about 10 to 11%. The Dry Eye market could account for more than 2.4 billion USD by 2014.
According to CBDMT, the market and business intelligence company, the Alzheimer's disease (AD) market was valued at $5.5 billion in 2009. The AD market is led by North America with a market share of 52% accounting for sales of $2.8 billion. The Alzheimer disease market could account for more than $10.1 billion by 2020.
Paris, le 29 janvier 2010 - COMCLOVIS, Agence Transversale en Stratégie, Création et Production, et CBDM.T, société de Market & Business Intelligence annoncent aujourd'hui la création d'un partenariat dans le domaine des sciences du vivant pour le compte des entreprises des industries pharmaceutiques, chimiques, cosmétiques et alimentaires.